Analysis of the mean change in sitting BP from baseline to the end of the study showed that differences in the baseline hypertension grade, PAC, PRA, eGFRcreat levels and serum K+ levels had no clear effect on BP-lowering effects of esaxerenone therapy. This evidence concerns the gene S100A6 and Hypertension.